On March 11 2020, as COVID continued to spread rapidly around the globe, the World Health Organization (WHO) officially ...

As we near the five-year anniversary of the COVID-19 pandemic, it's a good time to revisit the drugmaker stock that was top ...

At its sprawling complex in Durham, N.C., Merck has opened a new $1 billion, 225,000-square-foot manufacturing plant slated ...

On this day five years ago, the World Health Organization (WHO) declared COVID-19 a global pandemic, shutting down daily life, crippling the economy and reshaping public health.While ...

Orders for Merck & Co's oral antiviral for COVID-19 helped to swell the drugmaker's first quarter revenues by a massive 50%, although underlying growth was also strong. Lagevrio (molnupiravir ...

Daiichi Sankyo is stepping up its interest in RNA therapies, teaming with Nosis Biosciences to design drug candidates capable ...

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

Only seven countries met World Health Organization (WHO) air quality standards last year, data showed on Tuesday, as ...

Data shows it can prevent six types of cancer. But anti-vaccine activists, including U.S. Health Secretary Robert F. Kennedy ...

The mRNA technology that was deployed so effectively in vaccines against COVID-19 has now been found to offer similar promise against cancer, according to Merck & Co and Moderna.

Barclays 27th Annual Global Healthcare Conference March 11, 2025 1:30 PM ETCompany ParticipantsRose Loughlin - EVP of ...